Ubs Group Ag Sanofi Call Options Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$45.39 - $50.36 $1.36 Million - $1.51 Million	30,000 New	30,000 $1.46 Million
Q3 2023 Nov 09, 2023	BUY	$50.95 - $55.2 $2.99 Million - $3.23 Million	58,600 New	58,600 $3.14 Million
Q3 2022 Nov 10, 2022	BUY	$37.22 - $100.5 $3.23 Million - $8.73 Million	86,900 New	86,900 $3.3 Million
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $1.36 Million - $1.51 Million	28,800 Added 32.0%	118,800 $5.95 Million
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $3.35 Million - $3.72 Million	70,000 Added 350.0%	90,000 $4.34 Million
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $752,600 - $824,400	20,000 New	20,000 $800,000

810

267M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $136B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.